Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14604 | 760 | 23.5 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
59 | 3 | ANESTHESIOLOGY//PAIN//CHRONIC PAIN | 88506 |
2563 | 2 | TRAMADOL//DIPYRONE//TAPENTADOL | 3711 |
14604 | 1 | DRUG INDUCED THROMBOCYTOPENIA//DRUG DEPENDENT ANTIBODIES//DRUG INDUCED IMMUNE HEMOLYTIC ANEMIA | 760 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DRUG INDUCED THROMBOCYTOPENIA | authKW | 430027 | 2% | 63% | 17 |
2 | DRUG DEPENDENT ANTIBODIES | authKW | 361584 | 2% | 75% | 12 |
3 | DRUG INDUCED IMMUNE HEMOLYTIC ANEMIA | authKW | 200884 | 1% | 100% | 5 |
4 | THROMBOCYTOPENIA | authKW | 160071 | 15% | 3% | 117 |
5 | DRUG INDUCED HAEMOLYSIS | authKW | 120530 | 0% | 100% | 3 |
6 | EX VIVO ANTIGEN | authKW | 120530 | 0% | 100% | 3 |
7 | IMMUNE HAEMOLYSIS | authKW | 91829 | 1% | 57% | 4 |
8 | DRUG DEPENDENT ANTIBODY | authKW | 90396 | 0% | 75% | 3 |
9 | DRUG DEPENDENT PLATELET ANTIBODY | authKW | 80353 | 0% | 100% | 2 |
10 | DRUG INDUCED IMMUNE THROMBOCYTOPENIA | authKW | 80353 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 9348 | 34% | 0% | 258 |
2 | Medicine, General & Internal | 1378 | 21% | 0% | 157 |
3 | Critical Care Medicine | 437 | 5% | 0% | 38 |
4 | Pharmacology & Pharmacy | 318 | 14% | 0% | 108 |
5 | Pediatrics | 70 | 4% | 0% | 33 |
6 | Medical Laboratory Technology | 58 | 2% | 0% | 13 |
7 | Infectious Diseases | 48 | 3% | 0% | 24 |
8 | Immunology | 40 | 5% | 0% | 41 |
9 | Toxicology | 32 | 3% | 0% | 21 |
10 | Pathology | 30 | 3% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHAR ATI SAHUJI MAHARAJ MED UNIV | 40177 | 0% | 100% | 1 |
2 | CLIN BIOLOGIST | 40177 | 0% | 100% | 1 |
3 | CLIN TRANSFUS MED CELLULAR THER Y | 40177 | 0% | 100% | 1 |
4 | ENFEKSIYON HASTALIKARI KLINIK MIKROBIYOL ANABILIM | 40177 | 0% | 100% | 1 |
5 | HASTAKLIKLARI ANABILIM DALI | 40177 | 0% | 100% | 1 |
6 | HEMATOL HEMATOTHER Y SERV | 40177 | 0% | 100% | 1 |
7 | HEMOSTASEOL TRANSFUSMES | 40177 | 0% | 100% | 1 |
8 | HPMED ONCOL UNIT MED ONCOL | 40177 | 0% | 100% | 1 |
9 | IMMUNOHEMATOL FUNDACAO PRO SANGUE HEMO SAO | 40177 | 0% | 100% | 1 |
10 | IMMUNOHEMATOLGY TRANSFUS MED | 40177 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSFUSION | 16428 | 7% | 1% | 56 |
2 | VOX SANGUINIS | 3675 | 3% | 0% | 19 |
3 | BRITISH JOURNAL OF HAEMATOLOGY | 2646 | 4% | 0% | 30 |
4 | AMERICAN JOURNAL OF HEMATOLOGY | 2415 | 3% | 0% | 19 |
5 | ANNALS OF PHARMACOTHERAPY | 2395 | 2% | 0% | 18 |
6 | THERAPIE | 1565 | 1% | 0% | 10 |
7 | BLOOD | 1552 | 5% | 0% | 37 |
8 | LOUVAIN MEDICAL | 1383 | 0% | 3% | 1 |
9 | CLINICAL COLORECTAL CANCER | 1357 | 1% | 1% | 4 |
10 | INDIAN JOURNAL OF PHARMACOLOGY | 1342 | 1% | 1% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NEUMAN, G , BOODHAN, S , WURMAN, I , KOREN, G , BITNUN, A , KIRBY-ALLEN, M , ITO, S , (2014) CEFTRIAXONE-INDUCED IMMUNE HEMOLYTIC ANEMIA.ANNALS OF PHARMACOTHERAPY. VOL. 48. ISSUE 12. P. 1594 -1604 | 29 | 88% | 4 |
2 | ARNDT, PA , GARRATTY, G , (2005) THE CHANGING SPECTRUM OF DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA.SEMINARS IN HEMATOLOGY. VOL. 42. ISSUE 3. P. 137-144 | 34 | 87% | 44 |
3 | GARRATTY, G , (2012) IMMUNE HEMOLYTIC ANEMIA CAUSED BY DRUGS.EXPERT OPINION ON DRUG SAFETY. VOL. 11. ISSUE 4. P. 635-642 | 24 | 100% | 19 |
4 | SALAMA, A , (2009) DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA.EXPERT OPINION ON DRUG SAFETY. VOL. 8. ISSUE 1. P. 73-79 | 33 | 80% | 19 |
5 | MAYER, B , BARTOLMAS, T , YUREK, S , SALAMA, A , (2015) VARIABILITY OF FINDINGS IN DRUG-INDUCED IMMUNE HAEMOLYTIC ANAEMIA: EXPERIENCE OVER 20 YEARS IN A SINGLE CENTRE.TRANSFUSION MEDICINE AND HEMOTHERAPY. VOL. 42. ISSUE 5. P. 333 -339 | 30 | 77% | 2 |
6 | ASTER, RH , CURTIS, BR , MCFARLAND, JG , BOUGIE, DW , (2009) DRUG-INDUCED IMMUNE THROMBOCYTOPENIA: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 7. ISSUE 6. P. 911 -918 | 34 | 63% | 73 |
7 | WILLIAMSON, DR , LESUR, O , TETRAULT, JP , PILON, D , (2014) DRUG-INDUCED THROMBOCYTOPENIA IN THE CRITICALLY ILL: A CASE-CONTROL STUDY.ANNALS OF PHARMACOTHERAPY. VOL. 48. ISSUE 6. P. 697-704 | 35 | 61% | 1 |
8 | NORTHROP, MS , AGARWAL, HS , (2015) CEFTRIAXONE-INDUCED HEMOLYTIC ANEMIA: CASE REPORT AND REVIEW OF LITERATURE.JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. VOL. 37. ISSUE 1. P. E63 -E66 | 21 | 91% | 4 |
9 | BENCARDINO, K , MAURI, G , AMATU, A , TOSI, F , BONAZZINA, E , PALMERI, L , QUERQUES, M , RAVERA, F , MENEGOTTO, A , BOIANI, E , ET AL (2016) OXALIPLATIN IMMUNE-INDUCED SYNDROME OCCURS WITH CUMULATIVE ADMINISTRATION AND RECHALLENGE: SINGLE INSTITUTION SERIES AND SYSTEMATIC REVIEW STUDY.CLINICAL COLORECTAL CANCER. VOL. 15. ISSUE 3. P. 213 -221 | 29 | 69% | 0 |
10 | ARNDT, PA , LEGER, RM , GARRATTY, G , (2012) SEROLOGIC CHARACTERISTICS OF CEFTRIAXONE ANTIBODIES IN 25 PATIENTS WITH DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA (CME).TRANSFUSION. VOL. 52. ISSUE 3. P. 602 -612 | 26 | 79% | 7 |
Classes with closest relation at Level 1 |